Dermavant Sciences Appoints Timothy S. Nelson and Kenneth E. Ludlum to Board of Directors


You May Also Like

BioSig Technologies Issues Shareholder Letter

Minneapolis, MN, Jan. 20, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...

G1 Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes

RESEARCH TRIANGLE PARK, N.C., Sept. 18, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), ...